November 26, 2022
Loading...
You are here:  Home  >  'Herceptin'
Latest

Amgen adds two cancer treatment biosimilars to the market

By   /  Monday, July 22nd, 2019  /  Latest news  /  Comments Off on Amgen adds two cancer treatment biosimilars to the market

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

FDA decides not to approve Amgen biosimilar, at least for now

By   /  Friday, June 1st, 2018  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on FDA decides not to approve Amgen biosimilar, at least for now

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen settles lawsuit, says biosimilar works as well as Herceptin

By   /  Thursday, July 21st, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on Amgen settles lawsuit, says biosimilar works as well as Herceptin

Amgen settled a lawsuit and released positive news about a breast cancer biosimilar this week. The Thousand Oaks-based biotech giant said July 20 the company reached a settlement stemming from a class action lawsuit involving shareholders who sued the company over shares bought from the company between April 22, 2004 and May 10, 2007. Amgen Read More →